ArticleJAMA oncology2019

Cost-effectiveness of Maintenance Capecitabine and Bevacizumab for Metastatic Colorectal Cancer.

Scott K Sherman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.